Positivity Rate for Opioids Added to DOT Drug Testing Panel Notably Higher than Traditional Opiates

Written By ESR News Blog Editor Thomas Ahearn Data from the Quest Diagnostics Drug Testing Index™ shows that the positivity rate for four opioids recently added to the U.S. Department of Transportation (DOT) drug test program was notably higher than the rate observed among more traditional opiates, according to a blog from Quest Diagnostics.

Opioid Crisis in America Will Lead to More Advanced Drug Testing for Opiates by Employers in 2018

Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, U.S. President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed executive agencies “to fight the opioid crisis” during a speech at the White House. The growing awareness of an opioid crisis in America by employers…

DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic

Written By ESR News Blog Editor Thomas Ahearn The U.S. Department of Transportation (DOT) has issued a final rule in the Federal Register that adds four semi-synthetic opioids – hydrocodone, oxycodone, hydromorphone, and oxymorphone – to its drug testing panel for DOT regulated industries, adds methylenedioxyamphetamine (MDA) as an initial test analyte, and removes the testing…